← All investors

Biotechnology Value Fund

51 portfolio companies · 6 on the map · $2.1B raised · 5 cities

Portfolio map

6 Biotechnology Value Fund portfolio companies on the map.

Portfolio companies

Janux Therapeutics
San Diego
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Biotechnology Research$898.9MEst. 2017
Avalo Therapeutics
Chesterbrook
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Biotechnology$606.5MEst. 2011
CG Oncology
Dallas
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Biotechnology Research$555.6MEst. 2010
Verastem Oncology
Needham
Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.
Biotechnology ResearchPublicEst. 2010
A
Allakos
Redwood City
Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.
Biotechnology ResearchPublic
AnaptysBio
San Diego
AnaptysBio is a biotechnology company that develops antibody therapeutics based on somatic hypermutation.
Biotechnology ResearchPublicEst. 2005

More portfolio companies

42 more Biotechnology Value Fund investments we track beyond the map — 51 tracked in total.

Portfolio map

6 Biotechnology Value Fund portfolio companies on the map.

Biotechnology Value Fund portfolio | CleraMap